Cancer Genetics reports 3Q loss

RUTHERFORD, N.J. (AP) _ Cancer Genetics Inc. (CGIX) on Thursday reported a loss of $633,000 in its third quarter.

The Rutherford, New Jersey-based company said it had a loss of 15 cents per share. Losses, adjusted for non-recurring gains, came to 16 cents per share.

The diagnostics company posted revenue of $8 million in the period.

The company's shares closed at $3.10. A year ago, they were trading at $1.15.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CGIX at https://www.zacks.com/ap/CGIX